Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1791

0.0012

0.11%

GBP/USD

1.3216

0.0040

0.31%

USD/JPY

112.12

-0.9080

-0.80%

USD/CHF

0.9887

-0.0048

-0.49%

EUR/GBP

0.8921

-0.0022

-0.25%

USD/CAD

1.2772

0.0003

0.02%

NZD/USD

0.6813

-0.0042

-0.62%

EUR/JPY

132.20

-0.9325

-0.70%

EUR/CHF

1.1657

-0.0044

-0.38%

Aclaris Therapts Cmn

NASDAQ: ACRSHealthcare / Biotechnology / USA
22.90+0.21+0.93%Vol 206 5081Y Perf -3.86%
Nov 17th, 2017 16:00
BID18.94 ASK22.95
Open22.63 Previous Close22.69
Pre-Market- After-Trading22.90
 - -%  - -%
Target Price
46.00 
Analyst Rating
Strong Buy 1.00
Potencial %
100.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/-79 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/-75 
Income Ranking
 —    -
Market Cap (mil)706 
Earnings Rating
Price Range Ratio 52wk %
12.14 
Earnings Date

Today's Price Range

22.4923.13

 

52wk Range

21.4733.25

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-14.51%
3 Months
-14.67%
6 Months
-14.73%
1 Year
-3.86%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ACRS22.900.21000.93
AAPL170.15-0.9500-0.56
GOOG1 019.09-13.4100-1.30
MSFT82.40-0.8000-0.96
XOM80.24-0.3200-0.40
WFC54.15-0.4500-0.82
JNJ138.00-0.8700-0.63
FB179.00-0.5900-0.33
GE18.21-0.0400-0.22
JPM98.14-0.3300-0.34
...

TickerPriceChg.%52 Week High
FL40.8228.1679.43
VIAB26.1510.3846.72
ROST72.259.9973.94
GPS29.406.9930.14
FOX30.486.5731.94
FOXA31.156.2432.60
SWN6.455.7412.85
TGT58.145.5279.33
KR23.415.0736.44
RRC18.034.8339.64
DISCA17.554.7130.25
DISCK16.464.7129.18
ULTA215.104.44314.86
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 22.90
Current Ratio 23.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin33.80
EBIT Margin-2 742.10
EBITDA Margin-2 725.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.93
PS Ratios 1 047.21
Price to Cash Flow -
Price to Free Cash Flow -13.00
Cash Flow Per Share -1.70
Price to Tangible Book3.28
Book Value per Share7.92
Enterprise Value (in ths.)488 442
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -35.08
Return on Assets (5Y Avg) -
ROA last 12 Months -32.85
Return on Capital (5Y Avg) -
ROC last 12 Months -35.08
Return on invested Capital Q -8.82
Return on invested Capital Y-36.70
Assets Turnover0.00
Receivables Turnover2.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)684
Revenue per Share 0.02
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Q03 2016-0.68-0.5026.47
Q02 2016-0.61-0.62-1.64
Q01 2016-0.50-0.65-30.00
Q04 2015-0.40-0.2830.00
Earnings Per EndEstimateRevision %Trend
12/2017 QR-0.9021.74Positive
12/2017 QR-1.15-2.68Negative
12/2017 FY-2.7311.94Positive
12/2018 FY-4.26-24.20Negative
Next Report Date7th Nov 2017
Estimated EPS Next Report-0.89
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume206 508
Shares Outstanding (in ths.)30 830
Trades Count1 430
Dollar Volume4 152 632
Avg. Volume274 806
Avg. Weekly Volume396 314
Avg. Monthly Volume269 873
Avg. Quarterly Volume282 486

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

68%32%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x